ipamorelin clinical trials human studies Ipamorelin/CJC-1295 (no DAC) Blend ipamorelin growth hormone secretagogue study

It is studied in research models, and its safety is not fully established

In men it also produced a measurable increase in lean body mass compared with placebo, along with improved insulin sensitivity and general well-being

the D-stereoisomer prevents recognition and cleavage by proteolytic enzymes that specifically recognize L-amino acids Following synthesis, the compound undergoes purification via reverse-phase HPLC and comprehensive analytical characterization including mass spectrometry to verify molecular weight, purity profiling to confirm 99% compositional accuracy, and structural verification to ensure proper amino acid linkage and stereochemistry

Such higher doses may increase the risk of side effects such as drowsiness, headache, dizziness or gastrointestinal issues

Its main active components include thymol, carvacrol, flavonoids, and volatile oils (Zhou et al., 2023)